4.2.3 - The Globalised Health Industry
This lesson explains how health care has become tied to global flows of capital, labour, ideas, and risk. That matters in sociology because the global health industry does not simply improve health: it also reveals who has power over medicine, whose illnesses are treated as profitable, and why inequalities between rich and poor countries can be reproduced through health itself.
Health as a global market
The globalised health industry refers to the way health care now operates across national borders through multinational drug companies, private providers, international agencies, and globally mobile patients and workers. In sociological terms, health is no longer only a local service delivered inside one welfare state. It is increasingly shaped by corporations, patents, trade rules, and global inequalities in income and political power.
A key starting point is the growth of the pharmaceutical industry. A small number of multinational companies dominate drug research, patents, production, and marketing. Patents matter sociologically because they turn knowledge into a private asset. A drug may be medically effective, but access to it still depends on whether patients, insurers, or governments can afford the price set by the patent holder. This helps explain why profitable illnesses in wealthy markets often attract more investment than diseases concentrated in poorer countries.
Commodification of health
The process by which health care, medicines, and even the body are treated as commodities to be bought, sold, and marketed for profit.
Navarro (2007) argues that neoliberal globalisation has widened health inequalities by extending market logic into health care. From this angle, the global health industry does not mainly follow need; it follows purchasing power. That is why lifestyle drugs, cosmetic treatments, and long-term treatments for wealthy consumers may attract heavy investment while diseases of poverty remain underfunded.
Tudor Hart (1971) developed the inverse care law: those who need health care most often get it least. In a global context, this idea becomes even sharper. Countries carrying a heavy burden of infectious disease may still have the weakest health systems and the least access to expensive medicines.
These global inequalities show up in major outcome measures too: poorer countries generally face lower life expectancy, higher infant mortality and weaker access to routine treatment, even when the relevant medical knowledge already exists.
Pharmaceutical companies also influence doctors, researchers, and governments through lobbying, sponsorship, and marketing. Sociologically, this matters because the medical profession is not completely separate from corporate power. Doctors may remain highly trusted professionals, but the wider system in which they prescribe and research medicines can be shaped by commercial priorities.
Mobility and global inequality
Globalisation also moves patients and professionals across borders. Medical tourism happens when patients travel abroad for treatment because it is cheaper, faster, or unavailable at home. This can benefit better-off patients who can compare global markets and purchase care elsewhere, but it also shows that health is increasingly organised as a transnational service industry rather than a purely national public good.
The same global mobility affects health workers. Wealthy countries often recruit doctors and nurses from lower-income countries where training has already taken place but wages and career opportunities are weaker. This is usually described as a brain drain. From a sociological point of view, the issue is not just migration itself. It is the unequal structure behind it: poorer states effectively subsidise richer ones by losing skilled staff they can least afford to lose.
A simple comparison helps here:
| Process | Benefit for richer states or consumers | Cost for poorer states or local populations |
|---|---|---|
| Medical tourism | Faster or cheaper treatment for travelling patients | Private hospitals may prioritise fee-paying outsiders over local patients |
| Health worker migration | Richer systems fill staff shortages without training all workers themselves | Sending countries lose scarce professionals and weaken already stretched services |
Marxists see both patterns as examples of unequal exchange. Wealthier countries and corporations are better able to convert global links into advantage, while poorer countries carry the social cost. A more global perspective agrees that health must be understood through flows between core and peripheral regions, not just within one nation-state.
A patient from Britain who pays for surgery abroad may experience shorter waiting times and lower costs. However, if the receiving country has clinics geared toward foreign clients while local residents struggle to access basic care, global choice for one group can deepen inequality for another.
Continue this lesson.
You’re previewing NovaLearn without an account. Create a free account to read the rest.
Create free account